Breast cancer studies funded by pharmaceutical companies are more likely to report positive, or beneficial, results than those funded by government or non-profit organizations, according to a new report in the Journal Cancer. That doesn't necessarily mean that the results are wrong, as Amanda Gardner points out in the Washington Post. You would expect drug companies to have a better track record
No comments:
Post a Comment